A COVID-19 Message from Joe Capper, President & CEO—Our Commitment to You
CardioNet Access
CardioNet PEMS
LifeWatch Connect
MedNet Access
INR Physician Portal
BioTel Research Cardiac Safety Portal
Improving the Quality of Care While Reducing Costs
Our remote monitoring technology has helped us build the world’s largest cardiac data network, making care more accurate, comprehensive and efficient.
4,000,000,000+
Processing over 4 billion heartbeats a day
1,000,000+
Monitoring over 1 Million patients per year
30,000+
Each month more than 30,000 physicians refer patients to our products
1,000,000+
Provided over 1 million reports to physicians with information for diagnosis and therapy management
50,000+
Over 50,000 monitoring devices – 29 U.S. patents and 34 international patents issued
$300,000,000+
Over $300 million invested in the technology and service platform
BioTel Heart is the leading provider of remote cardiac monitoring diagnostic services.
Need help with your heart monitor?
Find product details, quick start guides and more at myheartmonitor.com.
BioTel Research is an industry leader in clinical trials testing services, monitoring, data, and scientific consulting.
Latest News
Only remote cardiac monitoring company whose proprietary connected system has FDA-approved indication to measure, analyze and report QT interval MALVERN, Pa., March 25, 2020 (GLOBE NEWSWIRE) — BioTelemetry, Inc. (NASDAQ:BEAT), a leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today announced […]
March 25, 2020
A COVID-19 Message from Joe Capper, President & CEO—Our Commitment to You
Dear BioTelemetry Community, The health and safety of you and your patients is our highest priority. As we work together during this challenging time, I want to assure you that we have never been more focused on making sure that you have the support you need from our company. It is our privilege to […]
March 23, 2020
BioTelemetry, Inc. Reports Fourth Quarter 2019 Financial Results
Announces Record Quarterly and Full Year Results MALVERN, Pa., Feb. 26, 2020 (GLOBE NEWSWIRE) — BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the quarter and year ended December 31, 2019. Quarter Highlights Recognized […]
February 26, 2020